Proteins are involved in every aspect of our lives, including as essential components of our immune system and as parts of viruses that can make us sick. When we take a medication, it binds to a specific protein in the body. This process changes the protein's function - and if it works properly, that can make us well.
In many diseases, the proteins that can trigger the disease state fit into very specific locations, like a biological keyhole. The protein of a potential drug for treating that disease must be designed to fit that keyhole. A good key and keyhole fit results in a more effective medicine with fewer side effects, but to achieve that fit, scientists need detailed knowledge of the structure of both proteins. One of the best ways to analyze a protein structure is to grow it in crystalline form.
Since 2005, the Kristallizator program from the State Space Corporation Roscosmos has created single protein crystals especially suited for analysis using X-ray diffraction. One outcome of these studies was identifying the structure of a target for anti-tuberculosis drugs, which could help scientists develop a treatment.
JAXA (Japan Aerospace Exploration Agency) has been active in protein crystal growth research in microgravity, accounting for about two-thirds of all PCG experiments on the station. A series of studies, JAXA PCG, has provided precise structures of many protein types and has led to the discovery of potential drugs.
One of these studies examined the crystal structure of a protein associated with Duchenne Muscular Dystrophy (DMD), a currently incurable genetic disorder. The work provided hints for compounds that could inhibit the disease, leading to several promising compounds, including one called TAS-205. The research team estimates the drug may slow the progression of DMD by half, increasing the lifespan of many patients. A clinical trial in human patients was completed in 2017. Co-investigator Mitsugu Yamada of JAXA says a larger Phase 3 trial to examine the effectiveness of TAS-205 in situations similar to actual clinical use began in December 2020 and will continue until 2027.
JAXA Moderate Temperature PCG continued this work, producing high quality crystals to advance basic biochemical knowledge and support drug discovery.
In addition to creating completely new treatments, PCG research on station can lead to drug formulations that are easier to store and last longer - such as those stable at room temperature that eliminate the need for refrigeration. This modification lowers the cost and simplifies distribution of drugs.
PCG-5, work sponsored by the ISS National Lab, focused on how drugs known as monoclonal antibodies are given to patients. Monoclonal antibodies do not dissolve easily in liquid and typically are delivered intravenously, requiring a patient to spend hours in a clinic setting. High-quality crystalline suspensions produced by PCG-5 could enable delivery by injection, making treatment more convenient for patients and caregivers and significantly reducing cost.
Merck Research Laboratories, developer of a series of PCG experiments, produced simple hardware and processes that scientists from other disciplines can use to conduct microgravity research. JAXA has worked to increase interest in PCG research in microgravity as well, developing a technology for membrane protein crystallization, for example. Other studies have advanced the field of protein crystallization by producing new processes for growing high-quality crystals aboard the space station.
By providing a platform for PCG research, the space station plays a key role in bringing people on Earth new and better treatments for diseases.
|Subscribe Free To Our Daily Newsletters|
NASA selects Emily Nelson as Chief Flight Director
Join the webinar on Accessibility in Human Spaceflight
Voyager will do more science with new power strategy
Creating new and better drugs with protein crystal growth experiments on the ISS
SpaceX aborts Starlink launch at last second, delays Falcon Heavy mission
Conservation groups sue US regulator over SpaceX launches
A second pair of SES' O3b mPower satellites launched on a SpaceX rocket
Falcon Heavy launches massive GEO satellite for Viasat
Examining a Potential Drill Spot: Sols 3817-3818
Just a Little Scoot: Sols 3814-3816
Sols 3812-3813: Tiny Sticks Poking Out at Us
Alberta researcher to help select samples to bring back from Mars
Final frontier is no longer alien
China to promote space science progress on five themes
China to develop satellite constellation for deep space exploration
China's space missions break new ground
Viper and T-Rex on double rocket launch|
ESA recruiting for key divisional directors
CGI to extend machine learning to LEO satellite network optimisation
Latest two O3b mPOWER satellites successfully launched for SES
Astra announces spacecraft engine contract with Apex
Deep-learning system explores materials' interiors from the outside
Innovative NASA alloy used for 3D printed rocket
Heed the reed: thatcher scientist on mission to revive craft
A stormy, active sun may have kickstarted life on Earth
Webb finds water vapor, but from a rocky planet or its star
Scientists discover rare element in exoplanet's atmosphere
Can ET detect us
Juice's first taste of science from space
New video series captures team working on NASA's Europa Clipper
Work continues to deploy Juice RIME antenna
Icy Moonquakes: Surface Shaking Could Trigger Landslides
|Subscribe Free To Our Daily Newsletters|